ArticleFrontiers in psychiatry2020

Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

Benedikt Bernd Claus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.